rss
Br J Ophthalmol 82:858-860 doi:10.1136/bjo.82.8.858
  • Commentary

Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis

Table 1

Administration of corticosteroids without antiparasitic drugs to patients with ocular toxoplasmosis

No of patients Age at onset >50 years
No (%) 		Evidence for primary aquired infection Corticosteroid administration Retinal scars
> 3 PD
No (%) 		Legal blindness of affected eye
No (%)
Laboratory
No (%) 		Clinical
No (%) 		Systemic
No (%) 		Periocular
No (%)
Literature survey 16 10  (63) NS 9  (56) 15  (94) 6  (38) 11  (69) 12  (75)
Present study 10 6 (60) 6 (60) 7 (70) 8 (80) 6 (60) 5 (50) 7 (70)
Total 26 16 (62) 16 (62) 23 (88) 12 (46) 16 (62) 19 (73)

  • ↵Chorioretinitis without associated old scars.

  • ↵See references 2–8; three patients received additional medication (two azathioprine, one sulphisoxazole respectively); five patients received systemic and periocular steroids.

  • Four patients received systemic and periocular steroids.

  • NS= not specified.

This Article

  1. Extract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.